Francesco Papaleo - Publications

Istituto Italiano di Tecnologia 

57 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Maltese F, Papaleo F. Oxytocin Discrepancies in Social Dynamics. Neuron. 107: 591-593. PMID 32818470 DOI: 10.1016/j.neuron.2020.07.027  0.92
2020 Scheggia D, Papaleo F. Social Neuroscience: Rats Can Be Considerate to Others. Current Biology : Cb. 30: R274-R276. PMID 32208153 DOI: 10.1016/j.cub.2020.01.093  1
2020 Romano GL, Platania CBM, Leggio GM, Torrisi SA, Giunta S, Salomone S, Purrello M, Ragusa M, Barbagallo C, Giblin FJ, Mastrogiacomo R, Managò F, Cammalleri M, Papaleo F, Drago F, et al. Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7. Scientific Reports. 10: 3972. PMID 32132582 DOI: 10.1038/s41598-020-60931-5  0.72
2020 Armando M, Ciampoli M, Padula MC, Amminger P, De Crescenzo F, Maeder J, Schneider M, Schaer M, Manago F, Eliez S, Papaleo F. Favorable effects of omega-3 polyunsaturated fatty acids in attentional control and conversion rate to psychosis in 22q11.2 deletion syndrome. Neuropharmacology. 107995. PMID 32057798 DOI: 10.1016/j.neuropharm.2020.107995  0.52
2020 Pagani M, De Felice A, Montani C, Galbusera A, Papaleo F, Gozzi A. Acute and Repeated Intranasal Oxytocin Differentially Modulate Brain-wide Functional Connectivity. Neuroscience. PMID 31917352 DOI: 10.1016/j.neuroscience.2019.12.036  0.4
2019 Scheggia D, Managò F, Maltese F, Bruni S, Nigro M, Dautan D, Latuske P, Contarini G, Gomez-Gonzalo M, Requie LM, Ferretti V, Castellani G, Mauro D, Bonavia A, Carmignoto G, ... ... Papaleo F, et al. Somatostatin interneurons in the prefrontal cortex control affective state discrimination in mice. Nature Neuroscience. PMID 31844317 DOI: 10.1038/s41593-019-0551-8  1
2019 Espinoza S, Scarpato M, Damiani D, Managò F, Mereu M, Contestabile A, Peruzzo O, Carninci P, Santoro C, Papaleo F, Mingozzi F, Ronzitti G, Zucchelli S, Gustincich S. SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson's Disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31495777 DOI: 10.1016/j.ymthe.2019.08.005  0.72
2019 Gorinski N, Bijata M, Prasad S, Wirth A, Abdel Galil D, Zeug A, Bazovkina D, Kondaurova E, Kulikova E, Ilchibaeva T, Zareba-Koziol M, Papaleo F, Scheggia D, Kochlamazashvili G, Dityatev A, et al. Attenuated palmitoylation of serotonin receptor 5-HT1A affects receptor function and contributes to depression-like behaviors. Nature Communications. 10: 3924. PMID 31477731 DOI: 10.1038/s41467-019-11876-5  1
2019 Contarini G, Ferretti V, Papaleo F. Acute Administration of URB597 Fatty Acid Amide Hydrolase Inhibitor Prevents Attentional Impairments by Distractors in Adolescent Mice. Frontiers in Pharmacology. 10: 787. PMID 31379568 DOI: 10.3389/fphar.2019.00787  0.88
2019 Ferretti V, Maltese F, Contarini G, Nigro M, Bonavia A, Huang H, Gigliucci V, Morelli G, Scheggia D, Managò F, Castellani G, Lefevre A, Cancedda L, Chini B, Grinevich V, ... Papaleo F, et al. Oxytocin Signaling in the Central Amygdala Modulates Emotion Discrimination in Mice. Current Biology : Cb. PMID 31178317 DOI: 10.1016/j.cub.2019.04.070  1
2019 Castellani G, Contarini G, Mereu M, Albanesi E, Devroye C, D'Amore C, Ferretti V, De Martin S, Papaleo F. Dopamine-Mediated Immunomodulation affects Choroid Plexus Function. Brain, Behavior, and Immunity. PMID 31175999 DOI: 10.1016/j.bbi.2019.06.006  0.88
2018 Ferretti V, Papaleo F. Understanding others: emotion recognition abilities in humans and other animals. Genes, Brain, and Behavior. e12544. PMID 30549185 DOI: 10.1111/gbb.12544  0.88
2018 Scheggia D, Mastrogiacomo R, Mereu M, Sannino S, Straub RE, Armando M, Managò F, Guadagna S, Piras F, Zhang F, Kleinman JE, Hyde TM, Kaalund SS, Pontillo M, Orso G, ... ... Papaleo F, et al. Publisher Correction: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment. Nature Communications. 9: 3560. PMID 30158661 DOI: 10.1038/s41467-018-06062-y  1
2018 Szczurkowska J, Pischedda F, Pinto B, Managò F, Haas CA, Summa M, Bertorelli R, Papaleo F, Schäfer MK, Piccoli G, Cancedda L. NEGR1 and FGFR2 cooperatively regulate cortical development and core behaviours related to autism disorders in mice. Brain : a Journal of Neurology. PMID 30059965 DOI: 10.1093/brain/awy190  0.72
2018 Scheggia D, Mastrogiacomo R, Mereu M, Sannino S, Straub RE, Armando M, Managò F, Guadagna S, Piras F, Zhang F, Kleinman JE, Hyde TM, Kaalund SS, Pontillo M, Orso G, ... ... Papaleo F, et al. Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment. Nature Communications. 9: 2265. PMID 29891954 DOI: 10.1038/s41467-018-04711-w  1
2017 Carr GV, Maltese F, Sibley DR, Weinberger DR, Papaleo F. The Dopamine D5 Receptor Is Involved in Working Memory. Frontiers in Pharmacology. 8: 666. PMID 29056909 DOI: 10.3389/fphar.2017.00666  1
2017 Managò F, Papaleo F. Schizophrenia: What's Arc Got to Do with It? Frontiers in Behavioral Neuroscience. 11: 181. PMID 28979198 DOI: 10.3389/fnbeh.2017.00181  0.72
2017 Ciampoli M, Contarini G, Mereu M, Papaleo F. Attentional Control in Adolescent Mice Assessed with a Modified Five Choice Serial Reaction Time Task. Scientific Reports. 7: 9936. PMID 28855580 DOI: 10.1038/s41598-017-10112-8  0.56
2017 Huang H, Guadagna S, Mereu M, Ciampoli M, Pruzzo G, Ballard T, Papaleo F. A schizophrenia relevant 5-Choice Serial Reaction Time Task for mice assessing broad monitoring, distractibility and impulsivity. Psychopharmacology. PMID 28378204 DOI: 10.1007/s00213-017-4611-z  0.92
2017 Contarino A, Kitchener P, Vallée M, Papaleo F, Piazza PV. CRF1 receptor-deficiency increases cocaine reward. Neuropharmacology. PMID 28137450 DOI: 10.1016/j.neuropharm.2017.01.024  1
2016 Galbusera A, De Felice A, Stefano G, Bassetto G, Maschietto M, Nishimori K, Chini B, Papaleo F, Vassanelli S, Gozzi A. Intranasal Oxytocin and Vasopressin Modulate Divergent Brainwide Functional Substrates. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27995932 DOI: 10.1038/npp.2016.283  0.4
2016 Managò F, Mereu M, Mastwal S, Mastrogiacomo R, Scheggia D, Emanuele M, De Luca MA, Weinberger DR, Wang KH, Papaleo F. Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia. Cell Reports. PMID 27524619 DOI: 10.1016/j.celrep.2016.07.044  1
2016 Papaleo F, Yang F, Paterson C, Palumbo S, Carr GV, Wang Y, Floyd K, Huang W, Thomas CJ, Chen J, Weinberger DR, Law AJ. Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 4859-75. PMID 27122041 DOI: 10.1523/JNEUROSCI.4632-15.2016  1
2016 Scheggia D, Papaleo F. An Operant Intra-/Extra-dimensional Set-shift Task for Mice. Journal of Visualized Experiments : Jove. PMID 26863331 DOI: 10.3791/53503  1
2016 Carr GV, Chen J, Yang F, Ren M, Yuan P, Tian Q, Bebensee A, Zhang GY, Du J, Glineburg P, Xun R, Akhile O, Akuma D, Pickel J, Barrow JC, ... Papaleo F, et al. KCNH2-3.1 expression impairs cognition and alters neuronal function in a model of molecular pathology associated with schizophrenia. Molecular Psychiatry. PMID 26857598 DOI: 10.1038/mp.2015.219  1
2015 Huang H, Papaleo F. Genetic modulation of oxytocin's effects in social functioning. Annals of Translational Medicine. 3: 348. PMID 26807403 DOI: 10.3978/j.issn.2305-5839.2015.09.36  0.92
2015 Papaleo F, Sannino S, Piras F, Spalletta G. Sex-dichotomous effects of functional COMT genetic variations on cognitive functions disappear after menopause in both health and schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26560201 DOI: 10.1016/j.euroneuro.2015.10.005  1
2014 Armando M, De Crescenzo F, Vicari S, Digilio MC, Pontillo M, Papaleo F, Amminger GP. Indicated prevention with long-chain polyunsaturated omega-3 fatty acids in patients with 22q11DS genetically at high risk for psychosis. Protocol of a randomized, double-blind, placebo-controlled treatment trial. Early Intervention in Psychiatry. PMID 25345540 DOI: 10.1111/eip.12197  1
2014 Moran PM, O'Tuathaigh CM, Papaleo F, Waddington JL. Dopaminergic function in relation to genes associated with risk for schizophrenia: translational mutant mouse models. Progress in Brain Research. 211: 79-112. PMID 24968777 DOI: 10.1016/B978-0-444-63425-2.00004-0  1
2014 Sannino S, Gozzi A, Cerasa A, Piras F, Scheggia D, Managò F, Damiano M, Galbusera A, Erickson LC, De Pietri Tonelli D, Bifone A, Tsaftaris SA, Caltagirone C, Weinberger DR, Spalletta G, ... Papaleo F, et al. COMT Genetic Reduction Produces Sexually Divergent Effects on Cortical Anatomy and Working Memory in Mice and Humans. Cerebral Cortex (New York, N.Y. : 1991). PMID 24658585 DOI: 10.1093/cercor/bhu053  1
2014 Papaleo F, Burdick MC, Callicott JH, Weinberger DR. COMT-Dysbindin epistatic interaction. Molecular Psychiatry. 19: 273. PMID 24557060 DOI: 10.1038/mp.2014.6  1
2014 Huang H, Michetti C, Busnelli M, Managò F, Sannino S, Scheggia D, Giancardo L, Sona D, Murino V, Chini B, Scattoni ML, Papaleo F. Chronic and acute intranasal oxytocin produce divergent social effects in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1102-14. PMID 24190025 DOI: 10.1038/npp.2013.310  1
2014 Papaleo F, Burdick MC, Callicott JH, Weinberger DR. Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans. Molecular Psychiatry. 19: 311-6. PMID 24145376 DOI: 10.1038/mp.2013.133  1
2014 Scheggia D, Bebensee A, Weinberger DR, Papaleo F. The ultimate intra-/extra-dimensional attentional set-shifting task for mice. Biological Psychiatry. 75: 660-70. PMID 23810621 DOI: 10.1016/j.biopsych.2013.05.021  1
2013 Giancardo L, Sona D, Huang H, Sannino S, Managò F, Scheggia D, Papaleo F, Murino V. Automatic visual tracking and social behaviour analysis with multiple mice. Plos One. 8: e74557. PMID 24066146 DOI: 10.1371/journal.pone.0074557  1
2013 Carr GV, Jenkins KA, Weinberger DR, Papaleo F. Loss of dysbindin-1 in mice impairs reward-based operant learning by increasing impulsive and compulsive behavior. Behavioural Brain Research. 241: 173-84. PMID 23261874 DOI: 10.1016/j.bbr.2012.12.021  1
2013 Zanotto M, Sona D, Murino V, Papaleo F. Dirichlet process mixtures of multinomials for data mining in mice behaviour analysis Proceedings of the Ieee International Conference On Computer Vision. 197-202. DOI: 10.1109/ICCVW.2013.33  1
2013 Armando M, Pontillo M, De Crescenzo F, Correale C, De Simoni E, Papaleo F, Saba R, Vicari S. An overview of correlations between schizophrenia and 22q11.2 deletion syndrome Clinical Neuropsychiatry. 10: 3-10.  1
2012 Papaleo F, Erickson L, Liu G, Chen J, Weinberger DR. Effects of sex and COMT genotype on environmentally modulated cognitive control in mice. Proceedings of the National Academy of Sciences of the United States of America. 109: 20160-5. PMID 23169629 DOI: 10.1073/pnas.1214397109  1
2012 Armando M, Saba R, Monducci E, Papaleo F, Dario C, Righetti V, Brandizzi M, Fiori Nastro P. [Subtypes of psychotic-like experiences in a community sample of young adults: socio-demographic correlates and substance use]. Rivista Di Psichiatria. 47: 424-31. PMID 23160053 DOI: 10.1708/1175.13033  1
2012 Law AJ, Wang Y, Sei Y, O'Donnell P, Piantadosi P, Papaleo F, Straub RE, Huang W, Thomas CJ, Vakkalanka R, Besterman AD, Lipska BK, Hyde TM, Harrison PJ, Kleinman JE, et al. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy. Proceedings of the National Academy of Sciences of the United States of America. 109: 12165-70. PMID 22689948 DOI: 10.1073/pnas.1206118109  1
2012 Scheggia D, Sannino S, Scattoni ML, Papaleo F. COMT as a drug target for cognitive functions and dysfunctions. Cns & Neurological Disorders Drug Targets. 11: 209-21. PMID 22483296  1
2012 Armando M, Papaleo F, Vicari S. COMT implication in cognitive and psychiatric symptoms in chromosome 22q11 microdeletion syndrome: a selective review. Cns & Neurological Disorders Drug Targets. 11: 273-81. PMID 22483289  1
2012 Ingallinesi M, Rouibi K, Le Moine C, Papaleo F, Contarino A. CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping. Molecular Psychiatry. 17: 1283-94. PMID 21946917 DOI: 10.1038/mp.2011.119  1
2012 Papaleo F, Lipska BK, Weinberger DR. Mouse models of genetic effects on cognition: relevance to schizophrenia. Neuropharmacology. 62: 1204-20. PMID 21557953 DOI: 10.1016/j.neuropharm.2011.04.025  1
2012 Papaleo F, Yang F, Garcia S, Chen J, Lu B, Crawley JN, Weinberger DR. Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Molecular Psychiatry. 17: 85-98. PMID 20956979 DOI: 10.1038/mp.2010.106  1
2012 Giancardo L, Sona D, Scheggia D, Papaleo F, Murino V. Segmentation and tracking of multiple interacting mice by temperature and shape information Proceedings - International Conference On Pattern Recognition. 2520-2523.  1
2012 Papaleo F. COMT as a drug target for nervous system disorders Cns and Neurological Disorders - Drug Targets. 11: 193-194.  1
2011 Papaleo F, Silverman JL, Aney J, Tian Q, Barkan CL, Chadman KK, Crawley JN. Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice. Learning & Memory (Cold Spring Harbor, N.Y.). 18: 534-44. PMID 21791566 DOI: 10.1101/lm.2213711  1
2011 Papaleo F, Weinberger DR. Dysbindin and Schizophrenia: it's dopamine and glutamate all over again. Biological Psychiatry. 69: 2-4. PMID 21145442 DOI: 10.1016/j.biopsych.2010.10.028  1
2009 Ji Y, Yang F, Papaleo F, Wang HX, Gao WJ, Weinberger DR, Lu B. Role of dysbindin in dopamine receptor trafficking and cortical GABA function. Proceedings of the National Academy of Sciences of the United States of America. 106: 19593-8. PMID 19887632 DOI: 10.1073/pnas.0904289106  1
2008 Papaleo F, Crawley JN, Song J, Lipska BK, Pickel J, Weinberger DR, Chen J. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 8709-23. PMID 18753372 DOI: 10.1523/JNEUROSCI.2077-08.2008  1
2008 Papaleo F, Ghozland S, Ingallinesi M, Roberts AJ, Koob GF, Contarino A. Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2878-87. PMID 18288089 DOI: 10.1038/npp.2008.8  1
2007 Papaleo F, Kieffer BL, Tabarin A, Contarino A. Decreased motivation to eat in mu-opioid receptor-deficient mice. The European Journal of Neuroscience. 25: 3398-405. PMID 17553008 DOI: 10.1111/j.1460-9568.2007.05595.x  1
2007 Papaleo F, Kitchener P, Contarino A. Disruption of the CRF/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal. Neuron. 53: 577-89. PMID 17296558 DOI: 10.1016/j.neuron.2007.01.022  1
2006 Papaleo F, Contarino A. Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice. Behavioural Brain Research. 170: 110-8. PMID 16580078 DOI: 10.1016/j.bbr.2006.02.009  1
2005 Contarino A, Papaleo F. The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal. Proceedings of the National Academy of Sciences of the United States of America. 102: 18649-54. PMID 16339307 DOI: 10.1073/pnas.0506999102  1
Show low-probability matches.